Meridian Diagnostics, Inc.
United StatesFDA applicant, unverified
- Devices
- 92
What Meridian Diagnostics, Inc. makes
Meridian Diagnostics, Inc. produces diagnostic reagents and media for microbiological testing, including fungal and bacterial antigen/antiserum products, chromogenic fluids for bacterial detection, and pre-packaged culture systems. Their portfolio covers rapid immunochromatographic tests (e.g., *IMMUNOCARD* formats) for pathogens like *Mycoplasma* and *E. coli* O157:H7, as well as specialized fungal culture media and staining solutions for clinical laboratories.
The company’s products are regulated under FDA’s Class I and Class II device classifications, with many cleared via the 510(k) pathway. Their diagnostic reagents and media are listed in the FDA’s 510(k) database, reflecting compliance with U.S. medical device regulations. The manufacturer operates from the United States.
Catalogue
Search and filter all 92 devicesShowing 1-50 of 92
Frequently asked questions
How many devices does Meridian Diagnostics, Inc. have in the registry?
The registry currently lists 92 devices for Meridian Diagnostics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Meridian Diagnostics, Inc.'s devices?
Among its 50 most recently registered devices, Meridian Diagnostics, Inc. has devices listed in FDA 510(k) (50 devices).
What risk classes do Meridian Diagnostics, Inc.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for Meridian Diagnostics, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Meridian Diagnostics, Inc. in the registry?
The most recently registered devices listed for Meridian Diagnostics, Inc. include BLASTOMYCES DERMATITIDIS, ANTIGEN, CANDIDA ALBICANS, ANTISERUM, LACTO-PHENOL ANALINE BLUE FLUID and IMMUNOCARD MYCOPLASMA.